Approval · Notice of Compliance 37632 · 2026
ACARBOSE TABLETS: Notice of Compliance 37632
Issued May 28, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37632
- Date
- May 28, 2026
- Company
- Strides Pharma Canada IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
- Canadian reference product
- GLUCOBAY (Bayer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACARBOSE TABLETS | 02493799 | Dormant |
Medicinal ingredients
- ACARBOSE 100 MG per TAB